Th Passeron

Summary

Country: France

Publications

  1. ncbi request reprint Melanin pigmentary disorders: treatment update
    Jean Paul Ortonne
    Service de Dermatologie, Hôpital L Archet 2, Nice, France
    Dermatol Clin 23:209-26. 2005
  2. ncbi request reprint Genetic disorders of pigmentation
    Thierry Passeron
    Department of Dermatology, Archet 2 Hospital, 06202 Nice Cedex 3, France
    Clin Dermatol 23:56-67. 2005
  3. ncbi request reprint Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure
    Nima Ostovari
    Arch Dermatol 142:252-3. 2006
  4. ncbi request reprint What's new in hypochromy
    Thierry Passeron
    Department of Dermatology, Hopital de l Archet 2, Nice, France
    J Dermatolog Treat 17:70-3. 2006
  5. doi request reprint [Pigmentary lasers]
    Thierry Passeron
    Service de Dermatologie, Hôpital Arche 2, CHU de Nice, 151, Route de Saint Antoine de Ginestiere, Nice Cedex 3, France
    Ann Dermatol Venereol 136:S325-9. 2009
  6. doi request reprint Treatment of granuloma annulare with the 595-nm pulsed dye laser, a multicentre retrospective study with long-term follow-up
    T Passeron
    Department of Dermatology, University Hospital of Nice, and INSERM U895, C3M, Team 12, Nice, France
    J Eur Acad Dermatol Venereol 27:785-8. 2013
  7. doi request reprint Lasers
    T Passeron
    Department of Dermatology, INSERM U1065, Nice CHU, France
    Ann Dermatol Venereol 139:S159-65. 2012
  8. doi request reprint Melasma pathogenesis and influencing factors - an overview of the latest research
    T Passeron
    Department of Dermatology, University Hospital of Nice, Nice, France
    J Eur Acad Dermatol Venereol 27:5-6. 2013
  9. doi request reprint [Lasers]
    T Passeron
    Service de Dermatologie, INSERM U1065, CHU de Nice, France
    Ann Dermatol Venereol 139:S108-14. 2012
  10. doi request reprint [What's new in dermatological research?]
    Th Passeron
    Service de Dermatologie and INSERM U895 équipe 1, CHU de Nice, Route de St Antoine de Ginestiere, 06200 Nice, France
    Ann Dermatol Venereol 137:S137-44. 2010

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Melanin pigmentary disorders: treatment update
    Jean Paul Ortonne
    Service de Dermatologie, Hôpital L Archet 2, Nice, France
    Dermatol Clin 23:209-26. 2005
    ..The treatment of hypomelanotic disorders is still often disappointing, but new therapeutic options provide encouraging results...
  2. ncbi request reprint Genetic disorders of pigmentation
    Thierry Passeron
    Department of Dermatology, Archet 2 Hospital, 06202 Nice Cedex 3, France
    Clin Dermatol 23:56-67. 2005
    ....
  3. ncbi request reprint Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure
    Nima Ostovari
    Arch Dermatol 142:252-3. 2006
  4. ncbi request reprint What's new in hypochromy
    Thierry Passeron
    Department of Dermatology, Hopital de l Archet 2, Nice, France
    J Dermatolog Treat 17:70-3. 2006
    ..New therapeutic approaches to hypochromy are further discussed...
  5. doi request reprint [Pigmentary lasers]
    Thierry Passeron
    Service de Dermatologie, Hôpital Arche 2, CHU de Nice, 151, Route de Saint Antoine de Ginestiere, Nice Cedex 3, France
    Ann Dermatol Venereol 136:S325-9. 2009
    ..Those limitations as well as the potential side effects have to clearly be explained to the patients that often seek for a miracle cure...
  6. doi request reprint Treatment of granuloma annulare with the 595-nm pulsed dye laser, a multicentre retrospective study with long-term follow-up
    T Passeron
    Department of Dermatology, University Hospital of Nice, and INSERM U895, C3M, Team 12, Nice, France
    J Eur Acad Dermatol Venereol 27:785-8. 2013
    ..In both cases, the treatment remains highly challenging. Isolated case reports suggested the interest of treating GA with a pulsed dye laser (PDL)...
  7. doi request reprint Lasers
    T Passeron
    Department of Dermatology, INSERM U1065, Nice CHU, France
    Ann Dermatol Venereol 139:S159-65. 2012
    ..In all cases, a precise diagnosis of the type of hyperpigmentation is mandatory before any laser treatment, and the limits and the potential side effects of the treatment must be clearly explained to patients...
  8. doi request reprint Melasma pathogenesis and influencing factors - an overview of the latest research
    T Passeron
    Department of Dermatology, University Hospital of Nice, Nice, France
    J Eur Acad Dermatol Venereol 27:5-6. 2013
    ..Identifying those associated factors should provide new targets for a more efficient treatment of melasma and a better prevention of the relapses...
  9. doi request reprint [Lasers]
    T Passeron
    Service de Dermatologie, INSERM U1065, CHU de Nice, France
    Ann Dermatol Venereol 139:S108-14. 2012
    ..In all cases, a precise diagnosis of the type of hyperpigmentation is mandatory before any laser treatment, and the limits and the potential side effects of the treatment must be clearly explained to patients...
  10. doi request reprint [What's new in dermatological research?]
    Th Passeron
    Service de Dermatologie and INSERM U895 équipe 1, CHU de Nice, Route de St Antoine de Ginestiere, 06200 Nice, France
    Ann Dermatol Venereol 137:S137-44. 2010
    ..Finally, physiopathological explanations have contributed to a variety of domains such as greying hair, axillary odors, HIV and herpes virus interrelations, and the teratogenicity of thalidomide...
  11. ncbi request reprint Use of the 308-nm excimer laser for psoriasis and vitiligo
    Thierry Passeron
    Department of Dermatology Archet 2 Hospital, 06202 Nice Cedex 3, France
    Clin Dermatol 24:33-42. 2006
    ..Combination with topical steroids appears to be synergistic and potentially reduces long-term side effects; again, prospective data are lacking...
  12. ncbi request reprint [The 308 nm excimer laser in dermatology]
    Thierry Passeron
    Service de Dermatologie, Hopital Archet, 2, Route de Saint Antoine de Ginestiere, 06200 Nice, France
    Presse Med 34:301-9. 2005
    ..Because of the sparcity of data and in the absence of long term follow-up, it must not be proposed in first intention...
  13. doi request reprint Evolution of nevi during treatment with natalizumab: A prospective follow-up of patients treated with natalizumab for multiple sclerosis
    Emeline Castela
    Department of Dermatology, University Hospital of Nice, France
    Arch Dermatol 147:72-6. 2011
    ..Although some fundamental data suggested that α₄β1 integrin could be linked to the invasiveness of melanoma, none showed any relation with the transformation of melanocytes...
  14. ncbi request reprint Physiopathology and genetics of vitiligo
    Thierry Passeron
    Department of Dermatology, Archet 2 Hospital, B P 3079, 06202 Nice Cedex 3, France
    J Autoimmun 25:63-8. 2005
    ..A recent genome-wide scan performed on families with numerous members presenting vitiligo has clearly revealed linkage of susceptibility loci...
  15. ncbi request reprint Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes
    Yuji Yamaguchi
    Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    FASEB J 22:1009-20. 2008
    ....
  16. ncbi request reprint 308-nm excimer laser therapy in alopecia areata
    Wassim Zakaria
    J Am Acad Dermatol 51:837-8. 2004
  17. ncbi request reprint Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo
    Thierry Passeron
    Department of Dermatology, Hopital de l Archet 2, Nice, France
    Arch Dermatol 140:1065-9. 2004
    ..To compare the efficacy of combined tacrolimus and 308-nm excimer laser therapy vs 308-nm excimer laser monotherapy in treating vitiligo...
  18. ncbi request reprint The new 940-nanometer diode laser: an effective treatment for leg venulectasia
    Thierry Passeron
    Department of Dermatology, Archet 2 Hospital, Nice, France
    J Am Acad Dermatol 48:768-74. 2003
    ..The 940-nm diode laser has been shown to be an effective treatment for leg veins...